For a full list of papers, visit our Google Scholar link.

  1. Prisco SZ, Hartweck L, Keen JL, Vogel N, Kazmirczak F, Eklund M, Hemnes AR, Brittain EL, and K.W. Prins. Glyoxylase-1 combats dicarbonyl stress and right ventricular dysfunction in rodent pulmonary arterial hypertension. Front Cardiovasc Med. 2022 Aug 25;9:940932
  2. F. Kazmirczak, L. Hartweck, S.Z. Prisco, and K.W. Prins. 2022. Intermittent Fasting Activates AMP Kinase to Restructure Right Ventricular Lipid Metabolism and Microtubules. BioRvix
  3. R. Al-Qazazi, P. Lima, S.Z. Prisco, F. Potus, A. Dasgupta, K. Chen, L. Tian, J. Mewburn, O. Jones, D. Wu, D. Maurice, S. Bonnett, S. Provencher, K.W. Prins, and S.L. Archer. Activation of the NLRP3 Inflammasome in Right Ventricular Macrophages Contributes to Right Ventricular Failure in Rodent and Human Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2022 Sep 1;206(5):608-624. doi: 10.1164/rccm.202110-2274OC
  4. Prisco, SZ, L. Hartweck, L. Rose, T. Thenappan, S.L. Archer, and K.W. Prins. 2022. Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility, Circ. Heart Fail. 15(1):e008574.
  5. Prisco, SZ, F. Kazmirczak, T. Thenappan, and K.W. Prins. 2022. Ingenuity Pathway Analysis of the Human Cardiac Cell Atlas Identifies Differences Between Right and Left Ventricular Cardiomyocytes. Pulm Circ. e12011.
  6. Prisco, SZ, M. Eklund, R. Raveendran, T. Thenappan, and K.W. Prins. 2021. With No Lysine Kinase 1 Promotes Metabolic Derangements and Right Ventricular Dysfunction in Pulmonary Arterial Hypertension. JACC Basic Trans Sci, 11(11): 834-850
  7. Prisco, SZ, M. Eklund, D. Moutsoglou, A. Khoruts, E.K. Weir, T. Thennapan, and K.W. Prins. 2021. Intermittent Fasting Enhances Right Ventricular Function in Preclinical Pulmonary Arterial Hypertension. JAHA. 10(22):e022722.
  8. Tatah, J, J. Keen, S.Z. Prisco, M. Pritzker, T. Thenappan, and K.W. Prins. 2021. Iron Deficiency is Associated with More Severe Pulmonary Vascular Disease in Pulmonary Hypertension due to Chronic Lung Disease. Chest. 161(1):232-236.
  9. Prisco, S.Z., T. Thenappan, and K.W. Prins. 2020. Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension. JACC Basic Trans Sci. 5(12): 1244-60
  10. J. Keen, S.Z. Prisco, and K.W. Prins. 2021. Sex Differences in Right Ventricular Dysfunction: Insights from the Bench and the Bedside. Front Physiol. 11:623129.
  11. Prins, K.W., T. Thenappan, R. Kalra, E.K. Weir, M. Pritzker, and S.L. Archer. 2019. Repurposing Medications for Pulmonary Arterial Hypertension: What’s Old is New Again. JAHA, 8:e011343